menu search

BMY / Biotech Breakthroughs: 3 Companies on the Cusp of Major Discoveries

Biotech Breakthroughs: 3 Companies on the Cusp of Major Discoveries
Artificial intelligence is changing the drug-discovery process by making it much faster and cheaper.  Traditionally, most biotech stock drug candidates fail. Read More
Posted: Aug 23 2023, 19:42
Author Name: InvestorPlace
Views: 103040

BMY News  

Bristol Myers Squibb Revenue Falls on Generic Competition for Key Drug

By Investopedia
October 26, 2023

Bristol Myers Squibb Revenue Falls on Generic Competition for Key Drug

Shares of Bristol Myers Squibb (BMY) fell Thursday after the company reported that sales of the drug maker's popular Revlimid blood cancer treatment p more_horizontal

Bristol Myers Squibb (BMY) Surpasses Q3 Earnings and Revenue Estimates

By Zacks Investment Research
October 26, 2023

Bristol Myers Squibb (BMY) Surpasses Q3 Earnings and Revenue Estimates

Bristol Myers Squibb (BMY) came out with quarterly earnings of $2 per share, beating the Zacks Consensus Estimate of $1.76 per share. This compares to more_horizontal

Bristol-Myers Squibb earnings top estimates

By Market Watch
October 26, 2023

Bristol-Myers Squibb earnings top estimates

Bristol-Myers Squibb Co. BMY, +0.87% on Thursday posted net income of $1.928 billion, or 93 cents a share, for the third quarter, up from $1.606 billi more_horizontal

Bristol Myers Squibb earnings top estimates even as top-selling drug fights generic competition

By CNBC
October 26, 2023

Bristol Myers Squibb earnings top estimates even as top-selling drug fights generic competition

Bristol Myers Squibb's revenue was in line with estimates, but fell slightly from the same period last year due to lower sales of blood cancer drug Re more_horizontal

Bristol Myers says it needs another year to hit target for new drugs

By Reuters
October 26, 2023

Bristol Myers says it needs another year to hit target for new drugs

Drugmaker Bristol Myers Squibb on Thursday pushed back by a year the time frame for its current new-product portfolio to hit $10 billion in sales as t more_horizontal

What's in Store for Bristol-Myers (BMY) in Q3 Earnings?

By Zacks Investment Research
October 23, 2023

What's in Store for Bristol-Myers (BMY) in Q3 Earnings?

Investors are likely to focus on Opdivo's demand along with an incremental contribution from newer drugs when Bristol-Myers (BMY) reports Q3 results. more_horizontal

Bristol-Myers Squibb Acquisition Of Mirati Makes Sense

By Seeking Alpha
October 22, 2023

Bristol-Myers Squibb Acquisition Of Mirati Makes Sense

Bristol Myers Squibb is a large pharmaceutical company with a strong dividend yield and impressive assets. The company's recent acquisition of Mirati more_horizontal

Top Wall Street analysts favor these five dividend stocks during tumultuous times

By CNBC
October 22, 2023

Top Wall Street analysts favor these five dividend stocks during tumultuous times

TipRanks' analyst ranking service pinpoints Wall Street's best-performing stocks, including Cisco and Chesapeake Energy. more_horizontal


Search within

Pages Search Results: